Company: VHC
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001140361-25-015742
Chunk: 29

Company: VirnetX Holding Corp
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 29
---
 (as defined in the Plan) of the Company. |

The following table shows the compensation earned by or paid to each of our non-employee directors for 2024:

| Name(1)           |     |         Fees 
    Earned or 
 Paid in Cash |     |     Stock 
 Awards(2) |     | Option    
 Awards(2) |     |    Total |
| Thomas M. O’Brien |     |     $110,000 |     |   $27,825 |     | $—        |     | $137,825 |
| Michael F. Angelo |     |     $100,000 |     |   $27,825 |     | $—        |     | $127,825 |
| Gary W. Feiner    |     |     $100,000 |     |   $27,825 |     | $—        |     | $127,825 |
| Heidy Chow        |     |   $37,500(3) |     |   $83,475 |     | $—        |     | $158,475 |

| (1) | This table includes the compensation of only non-employee directors. For Mr. Larsen’s compensation, please see “Executive Compensation and Other Matters” of this Proxy Statement. |

| (2) | The amounts in this column reflect the aggregate grant date fair value of the stock awards and option awards computed in accordance with Financial Accounting Standards Board’s Accounting Standards Codification Topic 718, or FASB ASC Topic 718. The Company calculates the fair value of restricted stock awards (“RSAs”) based on the fair market value of the Company’s common stock on the grant date. There can be no assurance that these amounts will ever be realized. For information on the valuation assumptions used in valuing these stock option awards, refer to Note 6 titled “Stock-Based Compensation” in the Notes to the Financial Statements contained in the Company’s Annual |

19

TABLE OF CONTENTS

Report on Form 10-K for fiscal year ended December 31, 2024. The Company has not granted stock option awards to its non-employee directors since the last grant in the fiscal year ended December 31, 2023.

| (3) | Ms. Chow’s compensation for the 2024 was pro-rated due to her appointment to the Board in June 2024. |

The following table lists all outstanding equity awards held by our non-employee directors as of December 31, 2024